======= RIC8A ======= == Gene Information == * **Official Symbol**: RIC8A * **Official Name**: RIC8 guanine nucleotide exchange factor A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=60626|60626]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NPQ8|Q9NPQ8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RIC8A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RIC8A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609146|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Ric8| |cell-cell adhesion involved in gastrulation| |cell migration involved in gastrulation| |basement membrane organization| |G-protein alpha-subunit binding| |visual learning| |visual behavior| |associative learning| |adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway| |guanyl-nucleotide exchange factor activity| |learning| |gastrulation| |ameboidal-type cell migration| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |cell-cell adhesion via plasma-membrane adhesion molecules| |learning or memory| |GTPase activator activity| |cognition| |response to light stimulus| |extracellular matrix organization| |in utero embryonic development| |extracellular structure organization| |positive regulation of GTPase activity| |response to radiation| |regulation of GTPase activity| |cell-cell adhesion| |vasculature development| |cardiovascular system development| |embryonic morphogenesis| |behavior| |chordate embryonic development| |embryo development ending in birth or egg hatching| |positive regulation of hydrolase activity| |circulatory system development| |cell adhesion| |biological adhesion| |cell migration| |embryo development| |cell motility| |localization of cell| |response to abiotic stimulus| |regulation of hydrolase activity| |locomotion| |G protein-coupled receptor signaling pathway| |nervous system process| |positive regulation of catalytic activity| |movement of cell or subcellular component| |positive regulation of molecular function| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp447|Amiloride 100μM R08 exp447]]|-2.76| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.73| |[[:results:exp534|Trientine 500μM R08 exp534]]|-2.68| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.53| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.36| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2.34| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-2.31| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.23| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|-2.23| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.17| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-2.15| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.08| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|-2.08| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-2.06| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.03| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.02| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.97| |[[:results:exp212|Phenformin 20μM R05 exp212]]|-1.95| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-1.93| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.78| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.75| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-1.72| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|1.9| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.17| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.26| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.36| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|2.44| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|2.51| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.69| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.94| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|3.44| |[[:results:exp264|Arsenate 40μM R06 exp264]]|4.84| ^Gene^Correlation^ |[[:human genes:g:gna13|GNA13]]|0.656| |[[:human genes:a:arhgef1|ARHGEF1]]|0.54| |[[:human genes:r:rhoa|RHOA]]|0.515| |[[:human genes:s:strada|STRADA]]|0.453| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18971 * **Expression level (log2 read counts)**: 6.57 {{:chemogenomics:nalm6 dist.png?nolink |}}